Method for quantifying glucose concentration and glucose concentration measurement device
US-2017027526-A1 · Feb 2, 2017 · US
US12533057B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12533057-B2 |
| Application number | US-202017771725-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 5, 2020 |
| Priority date | Nov 8, 2019 |
| Publication date | Jan 27, 2026 |
| Grant date | Jan 27, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is provided with a four-wavelength light emitter that emits four kinds of wavelengths of light toward a predetermined site on a living body; a light receiver that receives the four kinds of wavelengths of light transmitted through the predetermined site on the living body; a received light intensity information acquirer that acquires received light intensity information for the four wavelengths on the basis of an optical signal received by the light receiver; an absorbance time change value acquirer that finds time change values of the absorbances corresponding to the four wavelengths on the basis of the received light intensity information of the four wavelengths; a calibration data table that stores calibration data for finding a predetermined component in blood based on the absorbance time change values; and a component concentration acquirer that finds the concentration of the predetermined component in the blood.
Opening claim text (preview).
The invention claimed is: 1 . A blood component concentration measurement device comprising: four LEDs that are configured to be driven, in order, for a predetermined time, wherein each of the four LEDs is configured to emit a different wavelength of light toward a predetermined site on a living body; a light receiver that is configured to receive light that is emitted from each of the four LEDs and transmitted though the predetermined site on the living body, a data input interface that receives an output from the light receiver corresponding to the different wavelength of light emitted by each of the four LEDs, wherein the data input interface obtains light data on the different wavelength of light emitted by each of the four LEDs and performs A/D conversion to convert the light data into light intensity information; a central processing unit; and a non-transitory computer-readable recording medium that stores executable instructions that define an absorbance time change value acquirer and that define a component concentration acquirer, the executable instructions that define the absorbance time change value acquirer cause the central processing unit to compute an intermediate parameter using the following equation: ( p A p B p C p D ) = ( a 1 b 1 c 1 d 1 a 2 b 2 c 2 d 2 a 3 b 3 c 3 d 3 a 4 b 4 c 4 d 4 ) ( ω λ 1 ω λ 2 ω λ 3 ω λ 4 )
using optical sensors, e.g. spectral photometrical oximeters · CPC title
for analysing liquids, e.g. polluted water · CPC title
for measuring glucose, e.g. by tissue impedance measurement · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.